Priorisation of rare diseases for public health surveillance PowerPoint PPT Presentation

presentation player overlay
1 / 10
About This Presentation
Transcript and Presenter's Notes

Title: Priorisation of rare diseases for public health surveillance


1
Priorisation of rare diseases for public health
surveillance
  • What means public health surveillance ?
  • WHY do we need to establish priority
  • What priorisation of rare diseases for health
    surveillance is not
  • What is the best approach to define priority in
    Rare diseases

2
Priorisation of rare diseases for public health
surveillance
  • What means public health surveillance ?
  • To produce indicators

3
Priorisation of rare diseases for public health
surveillance
  • What means public health surveillance ?
  • To produce reliable indicators

4
Priorisation of rare diseases for public health
surveillance
  • What means public health surveillance ?
  • To produce reliable indicators
  • Various epidemiological tools
  • Cross-sectional studies
  • Cohort / retrospective prospective
  • Register

5
Priorisation of rare diseases for public health
surveillance
  • WHY do we need to establish priority among RD ?
  • A major reason
  • numerous RD
  • reliable indicators are defined for precise
    disease
  • limited resources
  • epidemiological techniques are quite costly
    register
  • Additional reasons
  • A rationale approach of the choices is warranted
  • The only way to be sure to monitor each disease
    which really need to be monitored

6
Priorisation of rare diseases for public health
surveillance
  • What priorisation of rare diseases for public
    health surveillance is not !
  • Priority for care
  • Priority for basic research
  • A moral ranking of the diseases

7
Priorisation of rare diseases for public health
surveillance
  • HOW ?
  • Need to have tools criteria of priorisation
  • Need to document each diseases
  • Need to rank the rare diseases for public health
    surveillance

8
Priorisation of rare diseases for public health
surveillance
  • Need to have tools criteria of priorisation
  • A Delphi method in France
  • A working group 10 including 3 representatives
    of patients association
  • A panel of 110 experts 90 medical experts or
    responsible of network in RD, 15 insurance or
    institution, 5 industrials

9
Priorisation of rare diseases for public health
surveillance
  • A Delphi method in France
  • round 1 July sept
  • round 2 mailing in feb see questionnaire
  • Expected results
  • multiple criteria approach
  • to define relative weight between criteria

10
Priorisation
  • Perspectives A review of a limited number of
    diseases (300 ?) since the end of 2006
  • Next Do the criteria and the priority could be
    endorsed by other country ? Do we need a global
    EU approach ?
Write a Comment
User Comments (0)
About PowerShow.com